16928-01-1

Basic information

• Product Name: Ethanone, 1-[3-(1,1-dimethylethyl)-4-hydroxyphenyl]-
• CAS NO: 16928-01-1
• Molecular Formula: C12H16O2
• Molecular Weight: 192.258
• Mol File: 16928-01-1.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: Ethanone, 1-[3-(1,1-dimethylethyl)-4-hydroxyphenyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Ethanone, 1-[3-(1,1-dimethylethyl)-4-hydroxyphenyl]-(16928-01-1)
• EPA Substance Registry System: Ethanone, 1-[3-(1,1-dimethylethyl)-4-hydroxyphenyl]-(16928-01-1)

Safety Data

• Hazardous Substances Data: 16928-01-1(Hazardous Substances Data)

Upstream product

• 88-18-6 2-tert-Butylphenol 
• 75-36-5 acetyl chloride 
• 3245-25-8 2-(tert-butyl)phenyl acetate 

Downstream Products

• 142651-19-2 1-(3-(tert-butyl)-4-methoxyphenyl)ethan-1-one 
• 1809653-01-7 1,3,5-tris(3’-tert-butyl-4’-hydroxy-5’-formylphenyl)benzene 
• 1142224-31-4 4-acetyl-2-(1,1-dimethylethyl)phenyl trifluoromethanesulfonate 
• 1095170-71-0 C₁₃H₁₇ClO₂ 
• 153356-02-6 1-(3-tert-Butyl-4-hydroxy-5-iodophenyl)ethanone 
• 153356-10-6 1-(5-bromo-3-tert-butyl-4-hydroxyphenyl)ethanone 
• 153356-04-8 1-[3-(tert-butyl)-4-hydroxy-5-nitrophenyl]-1-ethanone 

Relevant articles and documents

Vanadium-Catalyzed Oxidative Intramolecular Coupling of Tethered Phenols: Formation of Phenol-Dienone Products

A mild and efficient method for the vanadium-catalyzed intramolecular coupling of tethered free phenols is described. The corresponding phenol-dienone products are prepared directly in good yields with low catalyst loadings. Electronically diverse tethered phenol precursors are well tolerated, and the catalytic method was effectively applied as the key step in syntheses of three natural products and a synthetically useful morphinan alkaloid precursor.

PHARMACEUTICAL COMPOSITION, USE OF 2-IMINOPYRROLIDINE DERIVATIVE FOR PRODUCTION OF PHARMACEUTICAL COMPOSITION, AND KIT FOR TREATMENT OR AMELIORATION OF HEART DISEASES

One embodiment of the present invention is a pharmaceutical composition comprising at least one specific 2-iminopyrrolidine derivative and at least one other compound (B). Another embodiment of the present invention is a pharmaceutical composition compris

CONFORMATIONALLY CONSTRAINED CARBOXYLIC ACID DERIVATIVES USEFUL FOR TREATING METABOLIC DISORDERS

The present invention provides compounds useful, for example, for treating metabolic disorders in a subject. Such compounds have the general formula I or the general formula III: where the definitions of the variables are provided herein. The present invention also provides compositions that include, and methods for using, the compounds in preparing medicaments and for treating metabolic disorders such as, for example, type II diabetes.